AI Revolutionizes Cardiovascular Drug Development with $1.4+ Billion in Strategic Investments - GlobeNewswire
9/10AI is revolutionizing cardiovascular drug development with over $1.4 billion in strategic investments as of July 2026, accelerating drug discovery and innovation in this critical health area.
